CAS NO: | 151096-09-2 |
规格: | 98% |
分子量: | 401.43 |
包装 | 价格(元) |
50mg | 电议 |
200mg | 电议 |
Background:
Moxifloxacin is an orally bio-available, broad spectrum bacterial gyrase-inhibiting fluoroquinolone antibiotic [1].
Moxifloxacin at 50 μg/mL has been reported to induce a significant reduction of viable cells. A remarkable anti-proliferative activity of moxifloxacin has been proved in the concentrations between 50 and 1500?μg/mL. Moreover, moxifloxacin could lead to signs of cellular damage which were seen like binucleation in a dose-dependent manner [2].
Rats intravenously injected with moxifloxacin at 100 mg/kg have shown the increase of Serum glucose and serum epinephrine?concentrations as well as the release of histamine. However, moxifloxacin at 75 mg/kg did not show any effects on serum epinephrine, glucose or histamine concentrations increase [3].
参考文献:
[1] Iatropoulos MJ1,?Jeffrey AM,?Enzmann HG,?von Keutz E,?Schlueter G,?Williams GM. Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic. Exp Toxicol Pathol.?2001 Oct;53(5):345-57.
[2] Sobolewska B1,?Hofmann J,?Spitzer MS,?Bartz-Schmidt KU,?Szurman P,?Yoeruek E. Antiproliferative and cytotoxic properties of moxifloxacin on rat retinal ganglion cells. Curr Eye Res.?2013 Jun;38(6):662-9.
[3] Ishiwata Y1,?Takahashi Y,?Nagata M,?Yasuhara M. Effects of moxifloxacin on serum glucose concentrations in rats. Biol Pharm Bull.?2013;36(4):686-90.